Evidence map›Paper›PMID 29881515›Full record

ArticleThe Pan African medical journal2017

The prevalence of hepatitis B virus among HIV-positive patients at Kilimanjaro Christian Medical Centre Referral Hospital, Northern Tanzania.

Tasilo Kamenya, Damian Jeremia Damian, James Samwel Ngocho, Rune Nathaniel Philemon, Michael Johnson Mahande, Sia Emmanueli Msuya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tasilo KamenyaKilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.
Damian Jeremia DamianDepartment of Community Medicine, KCMC Hospital, Moshi, Tanzania.
James Samwel NgochoKilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.
Rune Nathaniel PhilemonDepartment of Paediatrics, KCMC Hospital, Moshi, Tanzania.
Michael Johnson MahandeDepartment of Epidemiology and Biostatistics, Institute of Public Health, KCMUCo, Moshi, Tanzania.
Sia Emmanueli MsuyaDepartment of Community Medicine, KCMC Hospital, Moshi, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHuman Immunodeficiency Virus (HIV) and hepatitis B virus are prevalent infections in sub-Saharan Africa, but information on the prevalence of co-infection is limited. This study aimed to determine seroprevalence and risk factors for hepatitis B virus infection among people living with HIV receiving care and treatment at Kilimanjaro Christian Medical Centre Referral Hospital in northern Tanzania.

methodsThis was a cross-sectional study conducted from March to June 2015 among people living with HIV (PLWHIV) aged 15 years and above attending the Care and Treatment Clinic for routine care at Kilimanjaro Christian Medical Centre. Systematic sampling was used to select the study participants. Information on socio-demographic data, sexual behaviour and medical history were collected using a questionnaire. Hepatitis B surface antigen was diagnosed using a rapid test. Descriptive statistics were used to summarize the data.

resultsA total of 300 PLWHIV consented to participate in this study, of whom 62% were female. Their ages ranged from 15-75 years, with a median age of 46 years (IQR of 39-53 years). The seroprevalence of hepatitis B surface antigen among people living with HIV was 2.3% (n=7/300). A history of blood transfusion was the only factor associated with hepatitis B surface antigen infection, while other socio-demographic and clinical factors showed no association.

conclusionHepatitis B virus infection is infrequent among PLWHIV in this setting. Despite the prevalence, we recommend routine screening for hepatitis B surface antigen and other hepatitis B virus markers among PLWHIV in order to tailor antiretroviral regimens against hepatitis B virus.

Indexed as

AdolescentAdultAgedCoinfectionCross-Sectional StudiesFemaleHepatitis BHepatitis B Surface AntigensHIV InfectionsHumansMaleMiddle AgedPrevalenceRisk FactorsSeroepidemiologic StudiesSurveys and QuestionnairesHepatitis B Surface Antigensco-infectionhepatitis B virusHepatitis B virusHuman Immunodeficiency VirusTanzania

Identifiers

PMID29881515
PMCPMC5989175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.